Evidence map›Paper›PMID 34644614›Full record

ArticleJournal of psychosomatic research2021

How orthopedic surgeons view open label placebo pills: Ethical and effective, but opposed to personal use.

Michael H Bernstein, Maayan Rosenfield, Nathaniel Fuchs, Molly Magill, Charlotte R Blease, Francesca L Beaudoin, Josiah D Rich, Karolina Wartolowska, Richard M Terek

Abstract read
In one paragraph

Article in Journal of psychosomatic research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael H BernsteinSchool of Public Health, Brown University, Center for Alcohol & Addiction Studies, United States of America. Electronic address: Michael_Bernstein@brown.edu.
Maayan RosenfieldSchool of Public Health, Brown University, Center for Alcohol & Addiction Studies, United States of America.
Nathaniel FuchsSchool of Public Health, Brown University, Center for Alcohol & Addiction Studies, United States of America.
Molly MagillSchool of Public Health, Brown University, Center for Alcohol & Addiction Studies, United States of America.
Charlotte R BleaseGeneral Medicine and Primary Care, Beth Israel Deaconess Medical Center, Harvard Medical School, United States of America.
Francesca L BeaudoinDepartment of Emergency Medicine, The Warren Alpert Medical School of Brown University, United States of America; Rhode Island Hospital & The Miriam Hospital, United States of America.
Josiah D RichSchool of Public Health, Brown University, Center for Alcohol & Addiction Studies, United States of America; Warren Alpert Medical School of Brown University, United States of America.
Karolina WartolowskaNuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom.
Richard M TerekWarren Alpert Medical School of Brown University, United States of America.

Funding

Project 4: Neonatal Abstinence Syndrome (NAS): Fetus to First YearsP20GM125507 · NIGMS · RHODE ISLAND HOSPITAL · PI JOSIAH D RICH · 2018 to 2026
$23.4M
Harnessing Placebo Analgesia to Address the Opioid EpidemicK01DA048087 · NIDA · RHODE ISLAND HOSPITAL · PI BERNSTEIN, MICHAEL HARRISON · 2019 to 2023
$903k
NIDA NIH HHS K01 DA048087NIGMS NIH HHS P20 GM125507
6 · The paper itself

Abstract

objectiveTo examine attitudes of Open Label Placebos (OLP) among a national sample of US orthopedic surgeons.

methodsOrthopedic surgeons across the US were invited to participate in a brief online cross-sectional survey; n = 687 participated. The survey included a short vignette of a surgeon using adjunctive OLPs in addition to opioids for postoperative pain management. Participants indicated how ethical and effective they thought OLPs would be in this context, and whether they would personally consider using OLPs.

resultsNearly three-quarters (73.9%) of the surgeons considered OLPs ethical. In total, 55.4% and 48.8% of participants said that OLPs would "probably" or "definitely" be effective for Vicodin reduction and pain relief, respectively. However, only 19.2% of participants indicated they were personally willing to consider OLPs, and 59.6% were unwilling to do so.

conclusionsGenerally, orthopedic surgeons perceive OLPs as both ethical and effective, but would not consider using them in their practice. Further research is needed to identify clinician barriers to OLP use.

Indexed as

Orthopedic SurgeonsAnalgesics, OpioidCross-Sectional StudiesHumansPain ManagementPlacebo EffectAnalgesics, OpioidOpen label placeboOpioidPainPain reductionPlacebo

Identifiers

PMID34644614
PMCPMC8633179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.